Demographic characterization of Brazilian patients enrolled in the Fabry Registry

被引:9
|
作者
Martins, A. M. [1 ]
Kyosen, S. O. [1 ]
Garrote, J. [1 ]
Marques, F. M. V. [2 ]
Guilhem, J. G. [3 ]
Macedo, E. [4 ]
Sobral Neto, J. [5 ]
Ura, S. [6 ]
机构
[1] Univ Fed Sao Paulo, Dept Pediat, Ctr Referencia Erros Inatos Metab, Sao Paulo, Brazil
[2] Hosp Santo Antonio, Tapejara, RS, Brazil
[3] Inst Hemodialise Sorocaba, Sorocaba, SP, Brazil
[4] Ctr Infusao Doencas Raras, Curimata, PI, Brazil
[5] Ctr Avaliacao Cardiol, Ctr Card, Brasilia, DF, Brazil
[6] Inst Lauro de Souza Lima, Bauru, SP, Brazil
关键词
Fabry disease; Alpha-galactosidase A deficiency; Fabry Registry; Brazil; Demographics; DISEASE; FEMALES;
D O I
10.4238/2013.January.24.5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fabry disease (FD) is an X-linked inborn error of metabolism caused by alpha-galactosidase A deficiency. The Fabry Registry is an ongoing observational database that compiles clinical data on patients with FD. We analyzed the Fabry Registry data of patients enrolled in Brazil to characterize the demographic and baseline clinical characteristics of this patient population. As of October 2010, 126 Brazilian patients were enrolled in the Registry (61 males, 65 females). The median age at onset of symptoms in males was 9.8 years, compared to 11.4 years in females. Males were diagnosed at a median age of 31.9 years and females at 27.1 years. The median time between the onset of first symptoms and diagnosis was 20.3 years in males and 14.3 years in females. Neurologic pain was the presenting symptom most frequently reported by both genders. Renal events were the most common clinical events reported in males, while cardiac events were the most common events in females. The results of these analyses indicate that Brazilian patients were frequently not diagnosed with FD until many years after the onset of symptoms. Many Brazilian Fabry Registry patients report experiencing neurological pain, and many Brazilian women with FD exhibit substantial signs and symptoms. The prevalence of neurological pain as a presenting symptom among Brazilian Registry patients is consistent with previous reports from the overall Registry population. FD is treatable, and earlier diagnosis will allow for prompt initiation of appropriate treatment that may avert irreversible damage that could occur during the time from symptom onset to diagnosis.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [21] Clinical and demographic characteristics of 131 patients with neuronopathic Gaucher disease enrolled in the Neurological Outcomes Sub-Registry of the ICGG Gaucher Registry
    Kolodny, Edwin
    Vellodi, Ashok
    El Beshlawy, Amal
    Cole, J. Alexander
    Tylki-Szymanski, Anna
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S27 - S27
  • [22] Demographic, clinical characteristics, managements strategies and in-hospital outcomes of patients enrolled in prospective nationwide SCAD registry
    Mehmedbegovic, Z.
    Krljanac, G.
    Ilic, I.
    Petrovic, M.
    Kovacevic, M.
    Djokovic, A.
    Mitov, V
    Zdravkovic, V
    Majstorovic, M.
    Iveljic, I.
    Radocic, D.
    Stankovic, S.
    Maricic, B.
    Bojovic, D.
    Apostolovic, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] CARDIAC OUTCOMES OF AGALSIDASE BETA TREATMENT FOR FABRY DISEASE: ANALYSIS OF CARDIOVASCULAR DISEASE PROGRESSION IN MEN ENROLLED IN THE FABRY REGISTRY
    Germain, D. P.
    Abiose, A.
    Patel, M. R.
    Weidemann, F.
    Benistan, K.
    Waldek, S.
    Strotmann, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S92 - S92
  • [24] The Fabry registry: early cardiac events in Fabry disease patients
    Bultas, J
    EUROPEAN HEART JOURNAL, 2004, 25 : 503 - 503
  • [25] Characterization Of Patients Enrolled In Respire, The Registry To Prospectively Evaluate Use Of Ventavis® In Patients With Pulmonary Arterial Hypertension
    Daniels, C. J.
    Studer, S. M.
    Rahaghi, F. F.
    McConnell, J.
    Elwing, J.
    Sager, J.
    Zolty, R.
    Petersen, S.
    Short, S.
    Villaneuva, D.
    Benton, W. W.
    Kim, N. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative
    Sirrs, S.
    Clarke, J. T. R.
    Bichet, D. G.
    Casey, R.
    Lemoine, K.
    Flowerdew, G.
    Sinasac, D. S.
    West, M. L.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (04) : 367 - 373
  • [27] Nephropathy in Fabry disease: Baseline characteristics of 1262 patients in the Fabry Registry
    Eng, Christine
    Ortiz, Alberto
    Oliveira, Joco
    Waldek, Steven
    Warnock, David
    Cianciaruso, Bruno
    Wanner, Christoph
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S20 - S21
  • [28] The demographic, genetic, and clinical characteristics of Brazilian subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey
    Cruz, Marcia Waddington
    Foguel, Debora
    Berensztejn, Amanda Cardoso
    Pedrosa, Roberto Coury
    Mundayat, Rajiv
    Ong, Moh-Lim
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 103 - 104
  • [29] PREGNANCY OUTCOMES IN PATIENTS ENROLLED IN THE GLOBAL AHUS REGISTRY
    Rondeau, Eric
    Ardissino, Gianluigi
    Caby-Tosi, Marie-Pierre
    Al-Dakkak, Imad
    Fakhouri, Fadi
    Miller, Benjamin
    Scully, Marie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [30] Baseline characteristics of PKU patients enrolled in the PKUDOS registry
    Burton, B. K.
    Longo, N.
    Arnold, G. L.
    Enns, G. M.
    Andersson, H. C.
    Mofidi, S.
    Peck, D.
    Prado, B. C.
    Pridjian, G.
    Waisbren, S.
    White, D.
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (03) : 273 - 273